Accepted at 5:44 a.m. Oct, 11, 2023 by Cameron
Author: Cameron
Related Note: 1477011423804
Rationale for change

Having mydriasis as a hint gives away answer. Testing point for card should not be which eye muscle causes mydriasis, should be whether or not a1 causes constriction or dilation and therefore through which pupillary muscle (dilator vs sphincter) imo

Text Text
Extra
Empty field
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid
Sketchy
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize
Physeo
Empty field
Bootcamp
OME
Additional Resources
Empty field
One by one
Empty field
#AK_Step1_v12::#SketchyPharm::01_Autonomic_Drugs::02_Sympathetic::01_Sympathomimetics #AK_Step1_v12::#Pixorize::03_Pharmacology::01_General_Pharm::03_Alpha-1_(Adrenergic)_Receptors #AK_Step1_v12::#Bootcamp::Pharmacology::03_Autonomic_System::04_Autonomic_System_Summary #AK_Step1_v12::#OME::PreClinical::General_Pharmacology::General_Principles_of_Pharmacology #AK_Step1_v12::#Osmosis::16_Neuro::01_Physiology::05_Sympathetic_nervous_system #AK_Step1_v12::#Bootcamp::Pharmacology::01_Pharmacodynamics::07_Membrane_Proteins #AK_Step1_v12::!FLAG_THESE_CARDS::Potential_duplicates #AK_Step1_v12::#B&B::17_Ophthalmology::01_General::01_Eye_Anatomy #AK_Step1_v12::#FirstAid::05_Pharm::03_Toxicities_and_Adverse_Effects::13_Drugs_affecting_pupil_size #AK_Step1_v12::#AMBOSS::vMaAqO #AK_Step1_v12::#B&B::16_Neuro::04_Autonomic_Nervous_System::01_Autonomic_Nervous_System #AK_Step1_v12::#B&B::17_Ophthalmology::01_General::02_Eye_Disorders::Extra #AK_Step1_v12::#Bootcamp::Pharmacology::01_Pharmacodynamics::08_Receptor_Physiology #AK_Step1_v12::#Low/HighYield::2-RelativelyHighYield #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::01_Autonomic_receptors::*Adrenergic_Receptors::a1 #AK_Step1_v12::#Costanzo::Autonomic::Overview #AK_Step1_v12::#B&B::16_Neuro::04_Autonomic_Nervous_System::02_Autonomic_Nervous_System_II #AK_Step1_v12::#SketchyPhysiology::02_Autonomic_Nervous_System::01_Organization_&_Feature_of_ANS::03_SNS_Effects_on_Organ_System #AK_Step1_v12::#Physeo::03_Physiology::01_General_Principles::03_Receptors_-_Part_1 #AK_Step1_v12::#FirstAid::05_Pharm::02_Autonomic_Drugs::05_G-protein-linked_second_messengers::*Adrenergic::a1 #AK_Other::#AK_Original_Decks::Step_1::Zanki_Pharmacology #AK_Step1_v12::#SketchyPhysiology::02_Autonomic_Nervous_System::02_Autonomic_Receptors::01_Adrenergic_Receptors(Adrenoreceptors)